Christos Mantzoros, MD, DSc
Christos Mantzoros is a Professor of Medicine at Harvard Medical School and at the Boston University School of Medicine. He serves as the Chief of Endocrinology, Diabetes and Metabolism at the Boston VA Healthcare System.
Dr. Mantzoros obtained an MD and DSc from the University of Athens Medical School, a Master's in Clinical Epidemiology from Harvard School of Public Health and a Master's in Medical Sciences (Clinical Investigation) from Harvard Medical School.
He has received Board certification in Internal Medicine, Endocrinology, Diabetes and Metabolism and in Clinical Nutrition.
At Harvard Medical School, he sees patients, teaches and conducts research on obesity and diabetes / metabolic diseases. His main research focus is the physiology, pathophysiology and potential therapeutic significance of adipokines, including leptin and adiponectin. Towards this goal his lab utilizes a range of basic, translational and clinical research tools.
Dr. Mantzoros is an internationally recognized expert on obesity and diabetes and has published as an Editor two books (one on "Diabetes and Obesity" and one on "Nutrition and Metabolism" with more than two editions each), and has authored more than 265 original papers, over 91 publications under the collaborative Look Ahead Research Group, as well as more than 120 chapters in textbooks and reviews. Dr. Mantzoros has received more than 18,500 citations with an H-index over 70. Dr. Mantzoros is the scientific co-founder of InteKrin Metabolic Therapeutics. He serves as the Editor-in-Chief of Metabolism, Clinical and Experimental, and is on the Editorial Board of several journals.
He has served as an advisor to Pharmaceutical and Diagnostics companies and has been given several awards including the prestigious American Association of Clinical Endocrinology Frontiers in Science Award, the Novartis Award in Diabetes and Metabolic Diseases, the Lilly Award by the North American Association for the Study of Obesity, the American Society for Nutrition Mead Johnson Award, the HypoCCS award in Paris, France, the Wilhelm Friedrich Bessel Award by the Humboldt Foundation of Germany, The Hygeia Award of the New England Hellenic Medical and Dental Society, the Outstanding Investigator Award by the American Federation of Medical Research and the Solomon Berson Award from the American Physiological Society and FASEB. He is also the recipient of the BIDMC and Harvard Medical School award for excellence in Mentoring. Dr. Mantzoros has been awarded Visiting and Honorary Professorships by several Universities worldwide and an honorary PhD by the Univ. of Thessaloniki Medical School in Greece. The Alexander Technological Institute of Thessaloniki, Greece has named its Clinical Research Laboratories after his name.
Dr. Mantzoros is the scientific co-founder of InteKrin Metabolic Therapeutics.